Results 21 to 30 of about 12,190,982 (354)

Why do we Discontinue Biologic Agents? A Retrospective Study of 11 Years

Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2020
Introduction: Biologic agents acquired a growing relevance in dermatology, however, adverse events (AE) and reasons to discontinue therapy are not completely known.
Francisco Gil, Margarida Rato, Ana Monteiro, Joana Parente, César Martins, João Aranha, Maria João Silva   +6 more
doaj   +1 more source

Access to infertility evaluation and treatment in two public fertility clinics and the reasons for withholding it: a prospective survey cohort study of healthcare professionals

BMJ Open, 2020
Objectives Study the proportion of patients affected by involuntary childlessness who are denied fertility treatment and the reasons behind this in a publicly funded healthcare system.
E. Elenis, A. Skoog Svanberg, P. Leandersson, Judith Lind, G. Sydsjö   +4 more
semanticscholar   +1 more source

Withholding of Life-Sustaining Treatment and Mortality in ICU Patients with Severe Acute COPD Exacerbations: A Retrospective French Cohort. [PDF]

Int J Chron Obstruct Pulmon Dis
Puechoultres P, Jamme M, Abi-Abdallah G, Diop S, Legriel S, Ferré A.   +5 more
europepmc   +3 more sources

Are medical ethicists out of touch? Practitioner attitudes in the US and UK towards decisions at the end of life [PDF]

, 2000
To assess whether UK and US health care professionals share the views of medical ethicists about medical futility, withdrawing/withholding treatment, ordinary/extraordinary interventions, and the doctrine of double effect.
Dickenson, Donna
core   +3 more sources

Perfil das condutas médicas que antecedem ao óbito de crianças em um hospital terciário A profile of the medical conduct preceding child death at a tertiary hospital

Jornal de Pediatria, 2005
OBJETIVO: estudar o perfil de assistência aos pacientes pediátricos que evoluem para o óbito em um hospital universitário, incluindo descrição dos modelos, comparações entre setores, associações de fatores, participações envolvidas e registro das ...
Henrique A.F. Tonelli, Joaquim A.C. Mota, José S. Oliveira   +2 more
doaj   +1 more source

The Ethics of Placebo-controlled Trials: Methodological Justifications [PDF]

, 2013
The use of placebo controls in clinical trials remains controversial. Ethical analysis and international ethical guidance permit the use of placebo controls in randomized trials when scientifically indicated in four cases: (1) when there is no proven ...
Grady, Christine, Millum, Joseph
core   +1 more source

The Brazilian policy of withholding treatment for ADHD is probably increasing health and social costs.

Revista Brasileira de Psiquiatria, 2015
OBJECTIVE To estimate the economic consequences of the current Brazilian government policy for attention-deficit/hyperactivity disorder (ADHD) treatment and how much the country would save if treatment with immediate-release methylphenidate (MPH-IR), as ...
C. R. Maia, S. F. Stella, P. Mattos, G. Polanczyk, C. Polanczyk, L. Rohde   +5 more
semanticscholar   +1 more source

The taxation of discrete investment choices [PDF]

, 1998
Traditional analysis of the taxation of income from capital has focused on the impact of tax on marginal investment decisions; the principal impact of tax on investment is through the cost of capital, and is generally measured by an effective marginal ...
Devereux, M.P., Griffith, R.
core   +2 more sources

Withholding and withdrawing life-sustaining therapy in a Moroccan Emergency Department: An observational study

BMC Emergency Medicine, 2011
Background Withdrawing and withholding life-support therapy (WH/WD) are undeniably integrated parts of medical activity. However, Emergency Department (ED) might not be the most appropriate place to give end-of life (EOL) care; the legal aspects and ...
Zekraoui Aicha, Madani Naoufel, Abidi Khalid, Dendane Tarek, Aggoug Badria, Belayachi Jihane, Damghi Nada, Benchekroun Belabes Abdellatif, Zeggwagh Amine Ali, Abouqal Redouane   +9 more
doaj   +1 more source

Reasons withholding intravenous thrombolysis for acute ischemic stroke in an Indonesian Tertiary Center

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2023
Background Intravenous thrombolysis is the current therapy of choice in patients with acute ischemic stroke (AIS). While highly effective, the rate at which the procedure is employed is low.
Rocksy Fransisca V. Situmeang, Aristo Pangestu, Reza Stevano, Yesenia Tannu, Jessica Herlambang, Cynthia Putri   +5 more
doaj   +1 more source